FDA 510(k)

ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A)

K 號：K210930 · 2021-11-29

決定日期2021-11-29

產品代碼LPL

諮詢委員會此為醫療器材法規文本之翻譯。根據醫療法規翻譯政策，以下為繁體中文譯文：本文件概述適用於醫療器材之監管架構，包括美國食品藥物管理局（FDA）之上市前審查程序。第510(k)條途徑適用於與已合法上市器材（predicate device）實質等效之器材，而上市前核准（PMA）則為最高風險等級（Class III）器材所要求。臨床證據可能引用NCT編號之試驗登記，或PMID編號之同行評審文獻。所有產品名稱、公司名稱、識別碼及統一資源定位符（URL）均保留原文，以確保可追溯性及法規提交之完整性。

決定相當於

器材摘要

ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A) is the device name listed in this FDA 510(k) record. The listed applicant is Johnson & Johnson Vision Care, Inc.. It received FDA 510(k) clearance on 2021-11-29 under 510(k) number K210930. The device is classified under product code LPL. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A)?

ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A) is a medical device that received FDA 510(k) clearance on 2021-11-29. The listed applicant is Johnson & Johnson Vision Care, Inc.. The 510(k) number is K210930.

When did ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A) receive FDA 510(k) clearance?

ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A) received FDA 510(k) clearance on 2021-11-29, under 510(k) number K210930.

Who is the listed applicant for ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A)?

The FDA 510(k) record lists Johnson & Johnson Vision Care, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A)?

The FDA product code for ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A) is LPL.

其他以 Johnson & Johnson Vision Care, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K200243ACUVUE (senofilcon A) 软性隐形眼镜多焦点 K180299ACUVUE OASYS (senofilcon A) with Photochromic Additive K160212ACUVUE (senofilcon C) 软性隐形眼镜

相關器械（代碼：LPL）

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。